top of page
â__Pngtreeâ__a_group_of_people_holding_16038099-transformed.jpeg

Pharmacovigilance Project Topics 

Expert Academic Project Help in Pharmacovigilance

We provide high-quality academic project reports, dissertations, internship projects, and research papers specifically focused on the Pharmacovigilance specialization.
Our Pharmacovigilance projects are suitable for students pursuing B.Pharm, M.Pharm or other management-related degrees. Each report is well-researched, formatted as per university guidelines, and designed to provide clear insights into Pharmacovigilance practices across industries.
Students can choose from a wide list of ready-made Pharmacovigilance project topics or request a fully customized report prepared according to their specific research area. Every project is developed purely for learning and reference purposes, helping you understand report structure, research methodology, and analysis so that you can confidently prepare your own Pharmacovigilance academic work.

Pharmacovigilance 500 Topics For Project Report

Pharmacovigilance Project Topics List (1–100)

1. Study of adverse drug reactions in hospitalized patients
2. Monitoring drug safety of anti-diabetic medications
3. Assessment of ADRs in cardiovascular drugs
4. Pharmacovigilance practices in herbal medicines
5. Evaluation of ADRs in oncology patients
6. Reporting patterns of adverse drug reactions in elderly patients
7. Assessment of ADRs in pediatric population
8. Pharmacovigilance study of antibiotics in a tertiary care hospital
9. Analysis of ADRs in anti-hypertensive therapy
10. Role of pharmacovigilance in post-marketing surveillance
11. Study of ADRs associated with NSAIDs
12. Evaluation of ADRs in antiviral therapy
13. Adverse drug reactions in patients on chemotherapy
14. Pharmacovigilance of newly approved drugs in hospital settings
15. Analysis of ADRs in cardiovascular combination therapy
16. Study of ADRs in patients taking corticosteroids
17. Assessment of ADRs in anti-epileptic drugs
18. Monitoring ADRs in anti-asthmatic medications
19. Pharmacovigilance in traditional and alternative medicines
20. Reporting and documentation of ADRs in clinical practice
21. Study of ADRs in anti-inflammatory drugs
22. Pharmacovigilance of vaccines in children
23. Assessment of ADRs in anti-malarial drugs
24. Analysis of ADRs in anti-tubercular therapy
25. Study of ADRs in psychotropic medications
26. Pharmacovigilance of biologic drugs
27. Reporting patterns of ADRs in diabetic patients
28. Assessment of ADRs in anti-thyroid drugs
29. Study of ADRs in anti-fungal therapy
30. Evaluation of ADRs in pain management therapy
31. Analysis of ADRs in immunosuppressive therapy
32. Study of ADRs in antipsychotic medications
33. Monitoring ADRs in anticoagulant therapy
34. Pharmacovigilance in herbal and nutraceutical products
35. Assessment of ADRs in anti-obesity medications
36. Study of ADRs in pediatric vaccinations
37. Analysis of ADRs in anti-viral combination therapy
38. Reporting ADRs in patients with renal disorders
39. Assessment of ADRs in anti-cancer targeted therapy
40. Study of ADRs in opioid analgesics
41. Pharmacovigilance of cardiovascular drugs in elderly patients
42. Evaluation of ADRs in diabetes combination therapy
43. Monitoring ADRs in anti-allergic medications
44. Study of ADRs in corticosteroid therapy
45. Assessment of ADRs in anti-hypertensive combination therapy
46. Analysis of ADRs in anti-migraine drugs
47. Pharmacovigilance of traditional medicines
48. Study of ADRs in patients receiving monoclonal antibodies
49. Reporting ADRs in patients with chronic kidney disease
50. Assessment of ADRs in anti-viral drugs
51. Study of ADRs in anti-diabetic therapy
52. Monitoring ADRs in chemotherapy-induced nausea
53. Analysis of ADRs in anti-tubercular combination therapy
54. Pharmacovigilance in hospitalized elderly patients
55. Study of ADRs in anti-epileptic combination therapy
56. Assessment of ADRs in cardiovascular intensive care units
57. Reporting patterns of ADRs in dermatological therapy
58. Evaluation of ADRs in anti-inflammatory drugs
59. Study of ADRs in monoclonal antibody therapy
60. Pharmacovigilance in pediatric oncology
61. Assessment of ADRs in anti-hypertensive monotherapy
62. Study of ADRs in anti-fungal therapy
63. Monitoring ADRs in anti-malarial combination therapy
64. Analysis of ADRs in psychotropic drug therapy
65. Reporting ADRs in patients receiving biologics
66. Assessment of ADRs in opioid therapy
67. Study of ADRs in diabetes monotherapy
68. Pharmacovigilance in herbal medicine combination therapy
69. Evaluation of ADRs in cardiovascular intensive care
70. Monitoring ADRs in anti-viral therapy
71. Study of ADRs in anti-asthmatic combination therapy
72. Assessment of ADRs in anti-cancer therapy
73. Reporting ADRs in hospitalized patients
74. Analysis of ADRs in monoclonal antibody therapy
75. Pharmacovigilance of antibiotics in ICU
76. Study of ADRs in anti-thyroid combination therapy
77. Assessment of ADRs in chemotherapy regimens
78. Monitoring ADRs in anti-obesity medications
79. Analysis of ADRs in traditional medicines
80. Reporting ADRs in anti-diabetic combination therapy
81. Study of ADRs in anti-hypertensive therapy
82. Pharmacovigilance in pediatric patients
83. Evaluation of ADRs in NSAID therapy
84. Monitoring ADRs in oncology patients
85. Study of ADRs in psychotropic combination therapy
86. Assessment of ADRs in anticoagulant therapy
87. Reporting ADRs in herbal medications
88. Analysis of ADRs in anti-migraine therapy
89. Study of ADRs in anti-fungal combination therapy
90. Pharmacovigilance of anti-cancer monoclonal antibodies
91. Assessment of ADRs in corticosteroid therapy
92. Study of ADRs in anti-epileptic monotherapy
93. Monitoring ADRs in cardiovascular therapy
94. Analysis of ADRs in opioid analgesics
95. Reporting ADRs in pediatric vaccinations
96. Assessment of ADRs in anti-thyroid therapy
97. Study of ADRs in anti-malarial therapy
98. Pharmacovigilance in elderly patients receiving polypharmacy
99. Evaluation of ADRs in biologic drug therapy
100. Monitoring ADRs in anti-diabetic therapy

​Why Students Prefer us

Custom-made project for your course and subject

Easy-to-understandand human written content

 Ready-made project for quick support

100% plagiarism-free and original work

Proper formatting, analysis, and organized content

Fast and secure delivery within 1 to 2 days

Pharmacovigilance Project Topics List (101-200)

101. Study of ADRs in anti-hypertensive combination therapy
102. Assessment of ADRs in psychotropic therapy
103. Reporting ADRs in oncology patients
104. Analysis of ADRs in anti-cancer combination therapy
105. Pharmacovigilance of anti-viral drugs
106. Study of ADRs in anti-obesity therapy
107. Assessment of ADRs in anti-asthmatic monotherapy
108. Monitoring ADRs in monoclonal antibody therapy
109. Analysis of ADRs in anti-diabetic therapy
110. Reporting ADRs in pediatric oncology
111. Study of ADRs in cardiovascular combination therapy
112. Assessment of ADRs in NSAID combination therapy
113. Pharmacovigilance in herbal product usage
114. Evaluation of ADRs in anti-viral combination therapy
115. Monitoring ADRs in chemotherapy regimens
116. Study of ADRs in opioid combination therapy
117. Assessment of ADRs in anti-thyroid combination therapy
118. Reporting ADRs in anti-fungal therapy
119. Analysis of ADRs in anti-migraine combination therapy
120. Study of ADRs in cardiovascular therapy
121. Pharmacovigilance in hospitalized diabetic patients
122. Assessment of ADRs in anti-epileptic combination therapy
123. Monitoring ADRs in anti-obesity medications
124. Analysis of ADRs in pediatric patients
125. Reporting ADRs in anti-cancer monoclonal antibody therapy
126. Study of ADRs in corticosteroid combination therapy
127. Assessment of ADRs in psychotropic medications
128. Pharmacovigilance in ICU settings
129. Evaluation of ADRs in cardiovascular monotherapy
130. Monitoring ADRs in anti-diabetic combination therapy
131. Study of ADRs in anti-hypertensive monotherapy
132. Assessment of ADRs in anti-viral therapy
133. Reporting ADRs in herbal and nutraceutical products
134. Analysis of ADRs in anti-inflammatory therapy
135. Study of ADRs in monoclonal antibody therapy
136. Pharmacovigilance of antibiotics in pediatric wards
137. Assessment of ADRs in anti-epileptic therapy
138. Monitoring ADRs in oncology combination therapy
139. Analysis of ADRs in opioid monotherapy
140. Reporting ADRs in anti-obesity combination therapy
141. Study of ADRs in anti-asthmatic therapy
142. Assessment of ADRs in cardiovascular therapy
143. Pharmacovigilance in geriatric patients
144. Evaluation of ADRs in anti-diabetic monotherapy
145. Monitoring ADRs in anti-cancer therapy
146. Study of ADRs in anti-hypertensive combination therapy
147. Assessment of ADRs in psychotropic combination therapy
148. Reporting ADRs in herbal medication use
149. Analysis of ADRs in anti-malarial therapy
150. Study of ADRs in NSAID therapy
151. Monitoring ADRs in anti-fungal combination therapy
152. Analysis of ADRs in anti-viral combination therapy
153. Reporting ADRs in monoclonal antibody therapy
154. Study of ADRs in chemotherapy-induced nausea
155. Assessment of ADRs in anti-obesity therapy
156. Pharmacovigilance in pediatric vaccination programs
157. Evaluation of ADRs in anti-hypertensive therapy
158. Monitoring ADRs in anti-diabetic therapy
159. Study of ADRs in psychotropic monotherapy
160. Assessment of ADRs in cardiovascular combination therapy
161. Reporting ADRs in herbal medicine usage
162. Analysis of ADRs in opioid therapy
163. Study of ADRs in anti-inflammatory drugs
164. Pharmacovigilance of biologics in hospitalized patients
165. Assessment of ADRs in corticosteroid therapy
166. Monitoring ADRs in anti-epileptic therapy
167. Analysis of ADRs in anti-cancer therapy
168. Reporting ADRs in elderly patients
169. Study of ADRs in NSAID combination therapy
170. Assessment of ADRs in anti-malarial drugs
171. Pharmacovigilance in ICU patients receiving polypharmacy
172. Evaluation of ADRs in anti-fungal therapy
173. Monitoring ADRs in anti-thyroid therapy
174. Study of ADRs in cardiovascular monotherapy
175. Assessment of ADRs in opioid combination therapy
176. Reporting ADRs in pediatric patients receiving vaccines
177. Analysis of ADRs in anti-asthmatic therapy
178. Study of ADRs in anti-diabetic combination therapy
179. Pharmacovigilance in oncology patients receiving biologics
180. Assessment of ADRs in anti-hypertensive monotherapy
181. Monitoring ADRs in herbal and nutraceutical products
182. Analysis of ADRs in psychotropic combination therapy
183. Reporting ADRs in anti-cancer monoclonal antibody therapy
184. Study of ADRs in corticosteroid combination therapy
185. Assessment of ADRs in anti-viral drugs
186. Pharmacovigilance in geriatric care
187. Evaluation of ADRs in anti-obesity combination therapy
188. Monitoring ADRs in anti-epileptic combination therapy
189. Study of ADRs in monoclonal antibody therapy
190. Assessment of ADRs in cardiovascular intensive care
191. Reporting ADRs in hospitalized pediatric patients
192. Analysis of ADRs in chemotherapy regimens
193. Study of ADRs in opioid monotherapy
194. Pharmacovigilance of antibiotics in pediatric wards
195. Assessment of ADRs in NSAID therapy
196. Monitoring ADRs in anti-diabetic monotherapy
197. Analysis of ADRs in anti-asthmatic combination therapy
198. Reporting ADRs in herbal medicines
199. Study of ADRs in anti-cancer combination therapy
200. Assessment of ADRs in psychotropic therapy

Helping Students Achieve Academic Excellence Every Day

📦

20,000+

Project Delivered

🎯

90+

Marks Secured

🧠

37,279+

Doubts Cleared

13,589+

Rating Count

Pharmacovigilance Project Topics List (201-300)

201. Pharmacovigilance in ICU settings
202. Evaluation of ADRs in anti-thyroid combination therapy
203. Monitoring ADRs in anti-fungal therapy
204. Study of ADRs in anti-hypertensive combination therapy
205. Assessment of ADRs in anti-obesity therapy
206. Reporting ADRs in pediatric oncology
207. Analysis of ADRs in opioid therapy
208. Study of ADRs in cardiovascular therapy
209. Pharmacovigilance in elderly patients receiving multiple drugs
210. Assessment of ADRs in anti-diabetic combination therapy
211. Monitoring ADRs in monoclonal antibody therapy
212. Analysis of ADRs in corticosteroid therapy
213. Reporting ADRs in herbal product usage
214. Study of ADRs in NSAID combination therapy
215. Assessment of ADRs in anti-cancer therapy
216. Pharmacovigilance of biologics in pediatric patients
217. Evaluation of ADRs in anti-epileptic therapy
218. Monitoring ADRs in anti-hypertensive therapy
219. Study of ADRs in psychotropic monotherapy
220. Assessment of ADRs in cardiovascular combination therapy
221. Reporting ADRs in oncology patients
222. Analysis of ADRs in anti-diabetic therapy
223. Study of ADRs in anti-fungal combination therapy
224. Pharmacovigilance in pediatric vaccination programs
225. Assessment of ADRs in anti-thyroid therapy
226. Monitoring ADRs in anti-obesity combination therapy
227. Analysis of ADRs in corticosteroid therapy
228. Reporting ADRs in elderly patients
229. Study of ADRs in opioid combination therapy
230. Assessment of ADRs in anti-cancer monoclonal antibody therapy
231. Pharmacovigilance in ICU patients
232. Evaluation of ADRs in anti-asthmatic therapy
233. Monitoring ADRs in anti-diabetic monotherapy
234. Study of ADRs in NSAID therapy
235. Assessment of ADRs in psychotropic combination therapy
236. Reporting ADRs in herbal and nutraceutical products
237. Analysis of ADRs in anti-cancer therapy
238. Study of ADRs in cardiovascular monotherapy
239. Pharmacovigilance in hospitalized pediatric patients
240. Assessment of ADRs in anti-epileptic combination therapy
241. Monitoring ADRs in anti-hypertensive therapy
242. Analysis of ADRs in monoclonal antibody therapy
243. Reporting ADRs in oncology patients
244. Study of ADRs in corticosteroid combination therapy
245. Assessment of ADRs in anti-fungal therapy
246. Pharmacovigilance of antibiotics in ICU
247. Evaluation of ADRs in anti-obesity therapy
248. Monitoring ADRs in anti-diabetic combination therapy
249. Study of ADRs in opioid monotherapy
250. Assessment of ADRs in pediatric vaccinations
251. Reporting ADRs in anti-cancer biologics
252. Analysis of ADRs in NSAID combination therapy
253. Study of ADRs in anti-hypertensive therapy
254. Pharmacovigilance in elderly patients receiving polypharmacy
255. Assessment of ADRs in psychotropic therapy
256. Monitoring ADRs in anti-asthmatic combination therapy
257. Analysis of ADRs in corticosteroid therapy
258. Reporting ADRs in herbal medicines
259. Study of ADRs in anti-diabetic therapy
260. Assessment of ADRs in anti-cancer combination therapy
261. Pharmacovigilance in ICU patients receiving multiple drugs
262. Evaluation of ADRs in monoclonal antibody therapy
263. Monitoring ADRs in anti-thyroid therapy
264. Study of ADRs in opioid combination therapy
265. Assessment of ADRs in anti-fungal therapy
266. Reporting ADRs in pediatric patients
267. Analysis of ADRs in NSAID therapy
268. Study of ADRs in cardiovascular combination therapy
269. Pharmacovigilance in oncology wards
270. Assessment of ADRs in anti-obesity combination therapy
271. Monitoring ADRs in anti-diabetic monotherapy
272. Analysis of ADRs in psychotropic medications
273. Reporting ADRs in herbal product users
274. Study of ADRs in anti-cancer monoclonal antibody therapy
275. Assessment of ADRs in corticosteroid combination therapy
276. Pharmacovigilance in geriatric care
277. Evaluation of ADRs in anti-hypertensive therapy
278. Monitoring ADRs in anti-epileptic therapy
279. Study of ADRs in NSAID monotherapy
280. Assessment of ADRs in anti-fungal combination therapy
281. Reporting ADRs in oncology patients
282. Analysis of ADRs in anti-obesity therapy
283. Study of ADRs in anti-diabetic therapy
284. Pharmacovigilance in pediatric ICU
285. Assessment of ADRs in anti-asthmatic therapy
286. Monitoring ADRs in monoclonal antibody therapy
287. Analysis of ADRs in opioid therapy
288. Reporting ADRs in elderly patients
289. Study of ADRs in psychotropic combination therapy
290. Assessment of ADRs in cardiovascular therapy
291. Pharmacovigilance of herbal medicines in clinical practice
292. Evaluation of ADRs in anti-cancer combination therapy
293. Monitoring ADRs in anti-thyroid therapy
294. Study of ADRs in corticosteroid therapy
295. Assessment of ADRs in NSAID combination therapy
296. Reporting ADRs in pediatric oncology
297. Analysis of ADRs in anti-diabetic combination therapy
298. Study of ADRs in opioid monotherapy
299. Pharmacovigilance in ICU polypharmacy patients
300. Assessment of ADRs in monoclonal antibody therapy

SAMPLE OF PROJECT
Thesis | Internship Project | Research Report

Pharmacovigilance Project Topics List (301-400)

301. Monitoring ADRs in anti-cancer biologics
302. Assessment of ADRs in pediatric vaccinations
303. Study of ADRs in anti-diabetic monotherapy
304. Reporting ADRs in ICU patients
305. Analysis of ADRs in opioid combination therapy
306. Study of ADRs in anti-hypertensive combination therapy
307. Pharmacovigilance in hospitalized elderly patients
308. Assessment of ADRs in corticosteroid therapy
309. Monitoring ADRs in anti-epileptic therapy
310. Analysis of ADRs in anti-fungal therapy
311. Reporting ADRs in herbal medicine users
312. Study of ADRs in NSAID therapy
313. Assessment of ADRs in anti-cancer combination therapy
314. Pharmacovigilance in pediatric wards
315. Evaluation of ADRs in psychotropic therapy
316. Monitoring ADRs in anti-obesity medications
317. Study of ADRs in monoclonal antibody therapy
318. Assessment of ADRs in anti-asthmatic combination therapy
319. Reporting ADRs in oncology patients
320. Analysis of ADRs in cardiovascular therapy
321. Study of ADRs in anti-thyroid therapy
322. Pharmacovigilance in ICU polypharmacy
323. Assessment of ADRs in anti-diabetic therapy
324. Monitoring ADRs in corticosteroid combination therapy
325. Analysis of ADRs in opioid monotherapy
326. Reporting ADRs in pediatric oncology
327. Study of ADRs in anti-inflammatory therapy
328. Assessment of ADRs in anti-hypertensive therapy
329. Pharmacovigilance in geriatric patients receiving polypharmacy
330. Evaluation of ADRs in NSAID combination therapy
331. Monitoring ADRs in anti-cancer therapy
332. Study of ADRs in psychotropic combination therapy
333. Assessment of ADRs in monoclonal antibody therapy
334. Reporting ADRs in herbal and nutraceutical products
335. Analysis of ADRs in anti-asthmatic therapy
336. Study of ADRs in anti-diabetic combination therapy
337. Pharmacovigilance in oncology wards
338. Assessment of ADRs in corticosteroid therapy
339. Monitoring ADRs in anti-fungal therapy
340. Analysis of ADRs in opioid therapy
341. Reporting ADRs in elderly patients
342. Study of ADRs in anti-hypertensive combination therapy
343. Assessment of ADRs in pediatric patients
344. Pharmacovigilance of herbal medicine usage
345. Evaluation of ADRs in anti-cancer combination therapy
346. Monitoring ADRs in anti-thyroid therapy
347. Study of ADRs in monoclonal antibody therapy
348. Assessment of ADRs in anti-obesity therapy
349. Reporting ADRs in ICU patients
350. Analysis of ADRs in corticosteroid combination therapy
351. Study of ADRs in NSAID monotherapy
352. Pharmacovigilance in pediatric ICU
353. Assessment of ADRs in anti-diabetic therapy
354. Monitoring ADRs in psychotropic therapy
355. Analysis of ADRs in anti-cancer monoclonal antibodies
356. Reporting ADRs in oncology patients
357. Study of ADRs in opioid combination therapy
358. Assessment of ADRs in anti-fungal therapy
359. Pharmacovigilance in elderly patients receiving multiple drugs
360. Evaluation of ADRs in cardiovascular therapy
361. Monitoring ADRs in anti-asthmatic combination therapy
362. Study of ADRs in monoclonal antibody therapy
363. Assessment of ADRs in anti-hypertensive therapy
364. Reporting ADRs in herbal medicine users
365. Analysis of ADRs in corticosteroid therapy
366. Study of ADRs in anti-diabetic combination therapy
367. Pharmacovigilance in ICU patients
368. Assessment of ADRs in anti-obesity therapy
369. Monitoring ADRs in anti-epileptic therapy
370. Analysis of ADRs in psychotropic monotherapy
371. Reporting ADRs in pediatric oncology
372. Study of ADRs in NSAID combination therapy
373. Assessment of ADRs in anti-cancer therapy
374. Pharmacovigilance in pediatric wards
375. Evaluation of ADRs in anti-thyroid therapy
376. Monitoring ADRs in corticosteroid combination therapy
377. Study of ADRs in monoclonal antibody therapy
378. Assessment of ADRs in anti-hypertensive combination therapy
379. Reporting ADRs in oncology patients
380. Analysis of ADRs in anti-diabetic therapy
381. Study of ADRs in opioid monotherapy
382. Pharmacovigilance in elderly patients
383. Assessment of ADRs in anti-asthmatic therapy
384. Monitoring ADRs in psychotropic therapy
385. Analysis of ADRs in anti-cancer biologics
386. Reporting ADRs in herbal product users
387. Study of ADRs in NSAID therapy
388. Assessment of ADRs in pediatric vaccinations
389. Pharmacovigilance in ICU polypharmacy
390. Evaluation of ADRs in anti-fungal combination therapy
391. Monitoring ADRs in anti-diabetic monotherapy
392. Study of ADRs in corticosteroid therapy
393. Assessment of ADRs in anti-cancer monoclonal antibody therapy
394. Reporting ADRs in oncology patients
395. Analysis of ADRs in opioid combination therapy
396. Study of ADRs in anti-hypertensive therapy
397. Pharmacovigilance in pediatric wards
398. Assessment of ADRs in anti-obesity therapy
399. Monitoring ADRs in anti-asthmatic combination therapy
400. Analysis of ADRs in psychotropic combination therapy

 How It Works: 7 Simple Steps to Get Your Project Report 

Step 1

Connect with Us (WhatsApp/Call Preferred)

​Start by reaching out via Call or WhatsApp for an instant reply.

 

You can also connect via

 

We’ll ask for your course (e.g., MBA, BBA, MCA, M.Com) and specialization (e.g., HR, Finance, Business Analytics, Logistics, Healthcare, etc.).

Step 2

Share Guidelines & Requirements

If your university has specific guidelines or formats, share them with us. Based on your course and academic timeline, we’ll identify what you need:

  • Synopsis

  • Interim Report

  • Final Project Report

  • PPT for Viva​​ ​

Whether you need just one or all of the above, we’ll tailor the process accordingly.

This visual represents the second step: sharing your university's specific guidelines and requirements. It highlights our commitment to aligning every project, thesis, and dissertation with academic standards. Whether you need a synopsis, an interim report, a final project, or a presentation for your viva, we ensure our process is tailored to your academic timeline and needs.

Step 3

Choose a Fresh Topic (or Share Yours)

We will provide you with a list of fresh and relevant topic suggestions based on your course specialization. You can go through the list and choose any topic that interests you. If you already have a topic in mind, feel free to share it with us.

 

Our team will review it and check whether it matches your academic course requirements and if there are enough research materials available. This step ensures that your project topic is not only interesting but also suitable and doable within your timeline.

This description is for the third step, where students choose a project topic. The image represents the process of selecting a fresh and relevant research topic or sharing your own. We ensure your topic is suitable for your academic course, covers your specialization, and has sufficient research material available, guaranteeing a high-quality outcome for your thesis, dissertation, or research paper.

Step 4

Submit Student Details via a Secure Form

We’ll share a detailed Google Form where you'll provide required academic details like:

👤Full Name

🎓 University Name

🆔 Roll Number

📘 Academic Year

📚 Course & Specialization

👨‍🏫 Guide Name

 

This ensures your project looks official, formatted, and submission-ready.

This image describes the fourth step in our process, where you submit your academic details. It shows how students provide essential information like their full name, university name, roll number, course, and guide name via a secure Google Form. This crucial step ensures that your project is officially formatted and submission-ready, meeting all institutional standards for your final report.

Step 5

Pay Just 20% Advance to Begin

Once everything is finalized, pay only 20% advance to start the work.

  • If your project includes a synopsis or interim report, it will be delivered under this advance itself.

  • Your project is then assigned to a dedicated subject matter expert who specializes in your domain.

This description highlights the fifth step: paying a 20% advance to start the project. It visually represents the secure transaction that initiates the work, ensuring your synopsis or interim report is delivered. This step guarantees that your project is assigned to a dedicated subject matter expert specializing in your field, whether it's Business Analytics, Logistics, or Healthcare Management.
100 %
20 %

Step 6

Preview Before Final Payment

Once the complete project is ready, you’ll receive screenshots or a sample file to review the structure and content. Only after your final approval, you'll be asked to pay the remaining balance.

 

This ensures full transparency and gives you complete confidence in the work. You’ll have the chance to request changes if anything needs to be updated before final delivery.

This description corresponds to the sixth step, which is all about transparency and trust. The image shows you will receive a preview of your completed project via screenshots or a sample file before making the final payment. This allows you to review the project's structure and content, ensuring your complete confidence and satisfaction before the final delivery of your thesis, dissertation, or research paper.

Step 7

Final Delivery in Word & PDF Format

Receive your full project in editable Word and  PDF formats via WhatsApp or Email.

Post-delivery, we also provide:

✔️ Viva Preparation Support

✔️ Help in Customizing Report per Guidelines

✔️ Quick Edits (if needed)

This final image description focuses on the seventh and final step of the process. It represents the secure and fast delivery of your complete project in editable Word and PDF formats via WhatsApp or email. This step also highlights our post-delivery support, including viva preparation, quick edits, and help in customizing your report according to your final guidelines

Pharmacovigilance Project Topics List (401-500)

401. Reporting ADRs in herbal and nutraceutical products
402. Study of ADRs in monoclonal antibody therapy
403. Assessment of ADRs in corticosteroid combination therapy
404. Pharmacovigilance in elderly ICU patients
405. Evaluation of ADRs in NSAID combination therapy
406. Monitoring ADRs in anti-diabetic combination therapy
407. Study of ADRs in anti-cancer therapy
408. Assessment of ADRs in opioid therapy
409. Reporting ADRs in pediatric oncology
410. Analysis of ADRs in anti-fungal therapy
411. Study of ADRs in cardiovascular therapy
412. Pharmacovigilance in ICU polypharmacy patients
413. Assessment of ADRs in anti-thyroid therapy
414. Monitoring ADRs in psychotropic therapy
415. Analysis of ADRs in anti-diabetic monotherapy
416. Reporting ADRs in herbal medicine users
417. Study of ADRs in corticosteroid therapy
418. Assessment of ADRs in anti-obesity combination therapy
419. Pharmacovigilance in pediatric wards
420. Evaluation of ADRs in anti-cancer monoclonal antibodies
421. Monitoring ADRs in anti-asthmatic therapy
422. Study of ADRs in NSAID monotherapy
423. Assessment of ADRs in opioid combination therapy
424. Reporting ADRs in oncology patients
425. Analysis of ADRs in anti-diabetic therapy
426. Study of ADRs in cardiovascular combination therapy
427. Pharmacovigilance in elderly patients receiving polypharmacy
428. Assessment of ADRs in monoclonal antibody therapy
429. Monitoring ADRs in corticosteroid combination therapy
430. Analysis of ADRs in anti-fungal therapy
431. Reporting ADRs in pediatric ICU patients
432. Study of ADRs in psychotropic combination therapy
433. Assessment of ADRs in anti-hypertensive therapy
434. Pharmacovigilance in oncology wards
435. Evaluation of ADRs in anti-obesity therapy
436. Monitoring ADRs in anti-diabetic combination therapy
437. Study of ADRs in anti-cancer therapy
438. Assessment of ADRs in opioid monotherapy
439. Reporting ADRs in herbal medicine users
440. Analysis of ADRs in NSAID combination therapy
441. Study of ADRs in corticosteroid therapy
442. Pharmacovigilance in ICU patients
443. Assessment of ADRs in pediatric oncology
444. Monitoring ADRs in anti-hypertensive combination therapy
445. Analysis of ADRs in monoclonal antibody therapy
446. Reporting ADRs in psychotropic therapy
447. Study of ADRs in anti-asthmatic combination therapy
448. Assessment of ADRs in anti-diabetic therapy
449. Pharmacovigilance in geriatric ICU patients
450. Evaluation of ADRs in anti-cancer biologics
451. Monitoring ADRs in opioid combination therapy
452. Study of ADRs in NSAID therapy
453. Assessment of ADRs in corticosteroid combination therapy
454. Reporting ADRs in pediatric wards
455. Analysis of ADRs in anti-diabetic combination therapy
456. Study of ADRs in monoclonal antibody therapy
457. Assessment of ADRs in anti-obesity therapy
458. Pharmacovigilance in oncology patients
459. Evaluation of ADRs in anti-asthmatic therapy
460. Monitoring ADRs in psychotropic combination therapy
461. Study of ADRs in anti-cancer therapy
462. Assessment of ADRs in anti-thyroid therapy
463. Reporting ADRs in herbal medicines
464. Analysis of ADRs in corticosteroid therapy
465. Study of ADRs in opioid therapy
466. Pharmacovigilance in pediatric ICU
467. Assessment of ADRs in anti-hypertensive therapy
468. Monitoring ADRs in NSAID therapy
469. Analysis of ADRs in anti-diabetic therapy
470. Reporting ADRs in oncology patients
471. Study of ADRs in monoclonal antibody therapy
472. Assessment of ADRs in anti-obesity combination therapy
473. Pharmacovigilance in ICU polypharmacy
474. Evaluation of ADRs in anti-cancer combination therapy
475. Monitoring ADRs in corticosteroid combination therapy
476. Study of ADRs in psychotropic therapy
477. Assessment of ADRs in anti-asthmatic combination therapy
478. Reporting ADRs in pediatric oncology
479. Analysis of ADRs in opioid combination therapy
480. Study of ADRs in anti-diabetic monotherapy
481. Pharmacovigilance in geriatric patients
482. Assessment of ADRs in monoclonal antibody therapy
483. Monitoring ADRs in anti-hypertensive combination therapy
484. Analysis of ADRs in anti-fungal therapy
485. Reporting ADRs in herbal and nutraceutical products
486. Study of ADRs in NSAID combination therapy
487. Assessment of ADRs in anti-cancer biologics
488. Pharmacovigilance in pediatric wards
489. Evaluation of ADRs in corticosteroid therapy
490. Monitoring ADRs in anti-diabetic combination therapy
491. Study of ADRs in opioid therapy
492. Assessment of ADRs in psychotropic combination therapy
493. Reporting ADRs in oncology patients
494. Analysis of ADRs in anti-asthmatic therapy
495. Study of ADRs in monoclonal antibody therapy
496. Assessment of ADRs in anti-obesity therapy
497. Pharmacovigilance in ICU patients
498. Monitoring ADRs in anti-cancer therapy
499. Study of ADRs in corticosteroid combination therapy
500. Assessment of ADRs in pediatric oncology

Plagiarism Check and Removal Service Available!

Plagiarism can seriously affect the credibility of your academic or professional documents. Whether it’s a research paper, assignment, internship project, dissertation report, or PowerPoint presentation, originality is key. Our plagiarism detection and removal services help you maintain the highest standards of authenticity and integrity in your work.

We don’t just detect copied content — we analyse, identify, and ethically rewrite any plagiarized sections. Additionally, we check for AI-generated content and humanize it to make sure your documents read naturally and professionally. Our services are fast, reliable, and fully confidential, helping you submit your work with confidence.​

Why Plagiarism-Free Content Matters

Plagiarism is not only unethical but can also lead to academic penalties, reputational damage, or rejection of your work. By ensuring originality:

 

  • You maintain academic credibility & professional integrity.

  • Your ideas are presented clearly & authentically.

  • You reduce the risk of unintentional copying.

  • Your work becomes unique, increasing its value for submission, publication, or presentation.

Illustration showing the importance of plagiarism-free content for maintaining academic credibility, originality, and professional integrity.

Our Services

Complete Plagiarism Check

Ethical Content Rewriting

Affordable Options

AI Content Detection & Humanization

Guaranteed 100% Originality

Guidance on Citations & Formatting

Detailed Plagiarism Report

Project Ready Within Timeline

Complete Privacy & Confidentiality 

What Types of Work We Handle

We specialize in checking and removing plagiarism from a variety of documents, including:​​

Research Papers – Academic or professional research papers.

Assignments – College, university, or professional assignments.

Internship Project – Report or presentations for internship submissions.

Dissertation Report – Thesis, dissertations, and final-year project report.

PowerPoint Presentations – Slideshows for academic, corporate, or professional use.

Submit Your Work with Confidence

Don’t risk your academic or professional reputation with plagiarized or poorly written content. Let us check, rewrite, and humanize your work so it meets the highest standards of originality and quality. Whether it’s a research paper, assignment, internship project, dissertation report, or PowerPoint presentation, we ensure your documents are plagiarism-free, AI-free, and fully humanized.

Submit_your_work_with_confidence_illustration_showing_a_sad_girl_holding_a_red_plagiarized

Why Choose Us?

At ResearchProject.in, we don’t just deliver report. We provide complete academic support for students across courses like MBA, BBA, B.Com, M.Com, MCA, MA, BCA, BHM, BA, B.Tech, HM, B.Pharm, M.Pharm, and M.Sc. Every project is designed to meet university standards while helping students learn research flow, formatting, and presentation.

1

Budget-Friendly Pricing

We understand that students and professionals often work with limited budgets. That’s why we offer affordable project assistance without compromising on quality. Our competitive pricing ensures you get expert support at a cost that fits your budget, making professional academic help accessible to everyone.

3

Expertise You Can Trust

We have dedicated expert teams for different specializations, ensuring that your project is handled by someone who understands your subject in depth. Whether it’s management, IT, finance, law, or engineering, our specialists provide accurate, well-researched, and domain-specific solutions tailored to your needs.

5

Fast & Efficient Service

Deadlines are critical, especially for academic submissions. Our streamlined process ensures we work quickly without sacrificing accuracy or attention to detail. We deliver project within your required timeframe so you can stay stress-free and confident.

7

Comprehensive Support

Support

We provide complete assistance for thesis writing, research project, dissertations, internship report, academic essays, and more. No matter your academic level or field, our team is equipped to guide you from research to final draft, ensuring a smooth project journey from start to finish.

9

Referral & Cashback Program

At ResearchProject.in, we reward our clients for sharing their success. If you refer friends or classmates to us, you can earn exciting cashback rewards. It’s a win-win — your friends get high-quality project assistance, and you get rewarded for spreading the word.

2

Plagiarism-Free Guarantee

99 % 7 %

Originality is at the heart of everything we do. We thoroughly check and remove any plagiarized sections from your work, ensuring that your content is unique and maintains academic integrity. You can be confident that your project will meet high originality standards without any compromise on quality.

4

Respect for Original Work

We value creativity and the effort that goes into creating original work. Our role is to enhance your content by removing plagiarism while keeping your authentic ideas intact. We help you maintain your personal writing style while ensuring your project meets originality and quality standards.

6

Confidentiality Assured

Your privacy is our priority. All your project files, research data, and personal details are kept strictly confidential. We use secure storage and encrypted communication to ensure that your documents remain safe from unauthorized access.

8

AI & Plagiarism Detection with Turnitin

We use Turnitin, the world’s most powerful plagiarism detection tool, to identify even the smallest traces of copied content. Our process also detects AI-generated text to ensure your work maintains a human-written tone. This dual check guarantees originality, authenticity, and compliance with academic standards.

10

Proven Track Record of Excellence

With countless satisfied students, researchers, and professionals across various fields, we have built a strong reputation for delivering reliable and high-quality work. Our consistent results and returning clients reflect the trust and confidence people place in our services.

Project Report Reviews From Our Students

Get in touch

Course Name
!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.
bottom of page